LEVOCABASTINE: 23 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
23
Total FAERS Reports
0
Deaths Reported
2
Hospitalizations
23
As Primary/Secondary Suspect
Nov 10, 1993
FDA Approved
Discontinued
Status
Active Ingredient: LEVOCABASTINE HYDROCHLORIDE · FDA Application: 020219 ·
First Report: 201404 · Latest Report: 20220617
What Are the Most Common LEVOCABASTINE Side Effects?
#1 Most Reported
Drug ineffective
3 reports (13.0%)
#2 Most Reported
Condition aggravated
3 reports (13.0%)
#3 Most Reported
Colitis microscopic
3 reports (13.0%)
All LEVOCABASTINE Side Effects by Frequency
No side effect data available.
Who Reports LEVOCABASTINE Side Effects? Age & Gender Data
Gender: 95.8% female, 4.2% male. Average age: 56.4 years. Most reports from: JP. View detailed demographics →
Is LEVOCABASTINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 2 | 0 | 1 |
| 2016 | 5 | 0 | 0 |
| 2018 | 3 | 0 | 1 |
| 2020 | 4 | 0 | 0 |
| 2021 | 2 | 0 | 0 |
| 2022 | 2 | 0 | 0 |
What Is LEVOCABASTINE Used For?
| Indication | Reports |
|---|---|
| Conjunctivitis allergic | 12 |
Official FDA Label for LEVOCABASTINE
Official prescribing information from the FDA-approved drug label.